<DOC>
	<DOCNO>NCT02688582</DOCNO>
	<brief_summary>For study , previously develop population pharmacokinetic ( popPK ) model cefepime ( Jonckheere et al. , submit JAC ) program Rugloop vII , software program drive infusion pump . By enter patient data ( gender , serum creatinine , age weight ) Rugloop II , patient-specific dose calculate give patient . This concept know Target Controlled Infusion ( TCI ) . The aim study prospectively validate popPK model use TCI .</brief_summary>
	<brief_title>Target-controlled Infusion Model Cefepime</brief_title>
	<detailed_description />
	<mesh_term>Cefepime</mesh_term>
	<mesh_term>Cephalosporins</mesh_term>
	<criteria>Male female patient 18 year age old , admitted hospital ICU require administration cefepime part treatment Patients within weight range 50 120kg Patients calculated creatinine clearance within range 15 &gt; 90 ml/min , allocate one three group describe . Written informed consent , possible surrogate consent , possible declaration inclusion emergency , patient inform consent sign soon possible . Patient arterial catheter place reason current study purpose Patients display acute chronic renal failure require renal replacement therapy Pregnancy Moribund patient Known sensitivity allergy cefepime Inclusion another study involve antimicrobial treatment . Patient participate research period exclusion currently require study protocol , ethical committee health authority . Patient already previously include trial</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>February 2016</verification_date>
	<keyword>Target Controlled Infusion</keyword>
	<keyword>Pharmacokinetics</keyword>
	<keyword>Cefepime</keyword>
	<keyword>critically ill patient</keyword>
</DOC>